News

The road to digital innovation in the pharma and healthcare space is going to take players across industries — from tech developers and engineers to researchers and clinicians, according to a panel of digital-focused VPs speaking at BIO 2018 in Boston.

Pharma companies are increasingly embracing the use of wearables and other connected devices to streamline and improve data collection in clinical trials.

Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception.

A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston.

The Salford Royal NHS Foundation Trust has tapped Healthy.

Deep breaths.

In addition to a Health Records API and various fitness updates to the Apple Watch, Apple made one more health announcement last week at WWDC: a slew of upgrades to ResearchKit including hearing, vision, and speech tests; an updated UI; and a new research API for monitoring Parkinson's tremors and dyskinesia.

Kibbutz Shefayim Israel-based deep learning startup Zebra Medical Vision has just closed a $30 million Series C funding round led by aMoon and Aurum Ventures with participation from Johnson & Johnson Innovation JJDC and Intermountain Healthcare.

San Francisco-based wearable tech company iBeat has announced new funding for its wearable continuous monitor, called Heart Watch.

Stakeholders across healthcare are beginning to weigh the benefits and challenges digital therapeutics could bring to their businesses, and pharma is no exception.